Previous close | 0.3500 |
Open | 0.4000 |
Bid | 0.0000 |
Ask | 2.3500 |
Strike | 22.50 |
Expiry date | 2024-07-19 |
Day's range | 0.4000 - 0.4000 |
Contract range | N/A |
Volume | |
Open interest | 5 |
Performance Analysis and Future Clinical Prospects
BOULDER, Colo., May 10, 2024--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will present at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 15, 2024, at 3:35 pm ET.
BOULDER, Colo., May 09, 2024--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2024 and recent business highlights.